Perceptive Advisors’s ChemoCentryx CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-192,680
Closed -$10M – 125
2022
Q3
$10M Sell
192,680
-249,000
-56% -$10.3M 0.29% 66
2022
Q2
$10.9M Sell
441,680
-1,213,399
-73% -$26.7M 0.34% 57
2022
Q1
$41.5M Buy
1,655,079
+239,633
+17% +$6.73M 0.86% 30
2021
Q4
$51.5M Buy
1,415,446
+865,446
+157% +$30.4M 0.79% 32
2021
Q3
$9.4M Buy
+550,000
New +$8.57M 0.14% 106
2020
Q3
– Sell
-10,252
Closed -$590K – 149
2020
Q2
$590K Hold
10,252
– – 0.01% 120
2020
Q1
$406K Buy
+10,252
New +$435K 0.01% 104

Other funds holding CCXI

Perceptive Advisors's CCXI Position: Q4 2022 in Review

Perceptive Advisors sold out of ChemoCentryx (CCXI) in Q4 2022, closing a stake of 192,680 shares — an estimated $10M sold.

Perceptive Advisors first reported a position in CCXI in Q1 2020 and held it in 7 quarters. The position peaked at $51.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Perceptive Advisors reported no remaining ChemoCentryx position as of Q4 2022 after selling out during the quarter.
  • Perceptive Advisors sold 192,680 ChemoCentryx shares in Q4 2022, an estimated $10M.
  • Perceptive Advisors first reported a position in ChemoCentryx in Q1 2020 and held it in 7 quarters.
  • Perceptive Advisors's ChemoCentryx position peaked at $51.5M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx as of Q4 2022.

Based on Perceptive Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.